MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0008398
Suraksha Pharma Private Limited - fmcg in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹55.47 Cr
▲ 24% YoY
Net profit · FY 2025
₹1.57 Cr
Net margin 2.8%
EBITDA · FY 2025
₹8.91 Cr
EBITDA margin 16.1%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹6.05 Cr
Issued & subscribed
Open charges
₹26.23 Cr
Satisfied ₹3.92 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
108
Provident fund records
About Suraksha Pharma Private Limited
Data last updated:
Suraksha Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 08 May 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1998PTC029377. Its GSTIN is 36AAECS9774Q1Z9 (Telangana). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹6.05 Cr. It is led by directors including Nageswararao Gupta Manepalli (Managing Director) and Raghva Tayaru Aswani Manepalli (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹55.47 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.57 Cr (net margin 2.8%) and EBITDA of ₹8.91 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.
The company has about 108 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹26.23 Cr and satisfied charges of ₹3.92 Cr on record. Court records list 21 cases involving the company, including 13 filed by the company and 8 filed against it; 9 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹57.1 Lakh; the latest was in September 2016. Its 4 peer companies in the FMCG industry (Formulations, Personal Care and Skin Care), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Hygiene Plus Limited with revenue of ₹104.86 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,049 overdue payments to 16 micro and small suppliers.
Suraksha Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0008398). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surakshapharma.com.
Company details
CIN U24230TG1998PTC029377
Registration Number 029377
Incorporation Date 08 May 1998
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0008398
CIN history
Suraksha Pharma has one previous CIN (Corporate Identification Number): U24230AP1998PTC029377. The current CIN is U24230TG1998PTC029377, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1998PTC029377 | Current |
| U24230AP1998PTC029377 | Previous |
Key People
Nageswararao Gupta Manepalli Managing Director Raghva Tayaru Aswani Manepalli Whole-Time Director Someswara Rao Manepalli Whole-Time Director Recognitions & Rankings of Suraksha Pharma
Contact details
Suraksha Pharma Private Limited's registered office is in Tirumalagiri, Telangana. Its website is surakshapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressHig 101 H.No.15 – 31 – 1, Phase – 5 D Mart Lane Kphb Colony, Hyderabad, Telangana, India – 500072
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of Suraksha Pharma Private Limited, buy the company report.
Comprehensive company report
Suraksha Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Suraksha Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Suraksha Pharma Private Limited, buy the company report.
Financials of Suraksha Pharma Private Limited
FY 2025 filings availableSuraksha Pharma Private Limited reported revenue of ₹55.47 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹55.47 Cr ▲ 24%
Net profit · FY 2025
₹1.57 Cr margin 2.8%
EBITDA · FY 2025
₹8.91 Cr margin 16.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 8%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 44%
3 years · compounded
▲ 35%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 24% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹55.47 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.1% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suraksha Pharma Private Limited, buy the company report.
Board of directors of Suraksha Pharma Private Limited
Suraksha Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Padmaja Rani Manepalli Also directs: MMC Health Care Limited, Scoat Pharma Private Limited | Director | 01 Apr 2016 | 10 Years 7 Months | Current |
| Raghva Tayaru Aswani Manepalli Also directs: Sumages Pharma Private Limited, MMC Health Care Limited | Whole-Time Director | 21 Feb 2019 | 7 Years 8 Months | Current |
| Nageswararao Gupta Manepalli Also directs: Hemp Tribe Private Limited, Surax Cosmetics Private Limited, Surax Healthcare Private Limited and 4 more | Managing Director | 13 May 1998 | 28 Years 5 Months | Current |
| Someswara Rao Manepalli Also directs: Hemp Tribe Private Limited, Sumages Pharma Private Limited, Surax Cosmetics Private Limited and 2 more | Whole-Time Director | 29 Sep 2006 | 20 Years 1 Months | Current |
Peer comparison
Suraksha Pharma Private Limited is compared with the 4 companies closest to it by revenue in the FMCG industry (Formulations, Personal Care and Skin Care), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hygiene Plus Limited | ₹104.86 Cr (FY 2025) | 8.0% | Dadri, Uttar Pradesh, India | |||
| Modi-Mundipharma Beauty Products Private Limited | ₹104.83 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Sirmaxo Chemicals Pvt Ltd | ₹103.62 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Makcur Laboratories Limited | ₹103.51 Cr (FY 2025) | 14.0% | Dehgam, Gujarat, India | |||
| Suraksha Pharma Private Limitedthis company | ₹55.47 Cr (FY 2025) | ₹1.57 Cr | 2.8% | 24.0% | 108 | Hyderabad, Telangana, India |
To see the full peer comparison of Suraksha Pharma Private Limited, buy the company report.
Auditor
Suraksha Pharma Private Limited is audited by Visweswara Rao & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Visweswara Rao & Associates | FY 2023 | 005774S |
Shareholding
The shareholding of Suraksha Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Suraksha Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹26.23 Cr
Satisfied charges
₹3.92 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jul 2026 | 101345169 | Others | ₹2.3 Cr | Open | |
| 31 Dec 2025 | 101221581 | Others | ₹2.75 Cr | Open | |
| 27 May 2025 | 101105281 | Others | ₹2.84 Cr | Open | |
| 05 Dec 2024 | 101015312 | Others | ₹3.38 Cr | Open | |
| 11 Jul 2012 | 10371023 | Others | ₹14.97 Cr | Open |
To see the full charge records of Suraksha Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Suraksha Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹57.1 Lakh; the latest was in September 2016.
Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹57.1 Lakh
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: M.V.K. Nageswara Rao HUF, M Nageswara Rao Gupta HUF, M Someswara Rao HUF Seller: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: M Someswara Rao HUF, M Nageswara Rao Gupta HUF, 2 individuals |
| May 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: M Nageswara Rao Gupta HUF Seller: an individual |
| Feb 2007 | Funding round | ₹57.1 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Suraksha Pharma Private Limited has 21 court cases on record: 13 filed by Suraksha Pharma, 8 filed against it. 9 cases are pending and 12 are disposed.
Total cases
21
Filed by the company
13
Filed against the company
8
Pending
9
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 2 | 6 |
| High courts | 9 | 6 | 3 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Layerly Pharmaceuticals Pvt. Ltd. Rep. by P. Uday Kiran. and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court | Court case (CRR) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
To see the full case history of Suraksha Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Suraksha Pharma Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,049 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 16)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pharmchem | |||
| Supreem Pharmaceuticals Mysore Private Limited | |||
| an individual supplier | |||
| Orchid Packaging | |||
| Roorkee Research & Analytical Labs Pvt Ltd |
To see the full MSME payment records of Suraksha Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Suraksha Pharma has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Surax Healthcare Private Limited | U24304TG2019PTC135155 | |
| MMC Health Care Limited | U93090TN1996PLC034651 |
To see the full group structure of Suraksha Pharma Private Limited, buy the company report.
Employees & EPFO
Suraksha Pharma Private Limited has a workforce of 108 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
108
Active EPFO establishments
1
GST
Suraksha Pharma has 5 GST registrations: 3 active and 2 cancelled or inactive.
Total GSTINs
5
Active
3
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECS9774Q1Z9 | Telangana | Active | 01 Jul 2017 |
| 05AAECS9774Q1ZE | Uttarakhand | Active | 01 Jul 2017 |
| 05AAECS9774Q2ZD | Uttarakhand | Active | 13 Jul 2017 |
To see the full GST registrations and return filing status of Suraksha Pharma Private Limited, buy the company report.
Recent activity
Suraksha Pharma Private Limited has 7 board changes on record since 1998: 4 appointments and 3 cessations. The latest: Raghva Tayaru Aswani Manepalli ceased to be Director on 01 Mar 2019.
Charges
A charge with Others amounted to Rs. 2.30 Cr with Charge ID 101345169 was registered on 23 Jul 2026.
Charges
A charge with Others amounted to Rs. 2.75 Cr with Charge ID 101221581 was registered on 31 Dec 2025.
Charges
A charge with Others of Rs. 14.97 Cr registered on 11 Jul 2012 with Charge ID 10371023 was modified on 31 Dec 2025.
AGM
Suraksha Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 31 Jan 2022 via Charge ID 100544902 with Others was fully satisfied on 02 Jun 2025.
Charges
A charge with Others amounted to Rs. 2.84 Cr with Charge ID 101105281 was registered on 27 May 2025.
Filing
Suraksha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 3.38 Cr with Charge ID 101015312 was registered on 05 Dec 2024.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100544902 was registered on 31 Jan 2022.
Ceased
Raghva Tayaru Aswani Manepalli ceased to be Director.
Appointed
Raghva Tayaru Aswani Manepalli was appointed as Whole-Time Director.
Ceased
Someswara Rao Manepalli ceased to be Director.
9 earlier events are in the company report.
Frequently asked questions
Suraksha Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 08 May 1998 (28+ years old) and is registered under CIN U24230TG1998PTC029377.
Suraksha Pharma has 4 current directors:
- Nageswararao Gupta Manepalli - Managing Director
- Raghva Tayaru Aswani Manepalli - Whole-Time Director
- Someswara Rao Manepalli - Whole-Time Director
- Padmaja Rani Manepalli - Director
The latest financial statements of Suraksha Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Suraksha Pharma is 36AAECS9774Q1Z9, registered in Telangana. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 05AAECS9774Q1ZE (Uttarakhand), 05AAECS9774Q2ZD (Uttarakhand).
The CIN (Corporate Identification Number) of Suraksha Pharma is U24230TG1998PTC029377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suraksha Pharma has 21 court cases on record: 13 filed by the company and 8 filed against it. 9 are pending. Most are in the district courts.
Suraksha Pharma was incorporated on 08 May 1998, making it 28+ years old. It is registered with the Registrar of Companies, Hyderabad.
Suraksha Pharma has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹57.1 Lakh; the latest was in September 2016.
The peers of Suraksha Pharma by revenue are Hygiene Plus Limited, Modi-Mundipharma Beauty Products Private Limited, Sirmaxo Chemicals Pvt Ltd, Makcur Laboratories Limited, all in the FMCG industry (Formulations, Personal Care and Skin Care), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Raghva Tayaru Aswani Manepalli ceased to be Director on 01 Mar 2019. Raghva Tayaru Aswani Manepalli was appointed as Whole-Time Director on 21 Feb 2019. Someswara Rao Manepalli ceased to be Director on 15 Nov 2018. Suraksha Pharma has 7 board changes on record in total.
Yes, Suraksha Pharma is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0008398).
Suraksha Pharma has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,049 overdue payments to 16 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages